Evidence map›Paper›PMID 33959023›Full record

ArticleFrontiers in pharmacology2021

Rajeev K Mehlotra, Andrea Gaedigk, Rosalind E Howes, Tovonahary A Rakotomanga, Arsene C Ratsimbasoa, Peter A Zimmerman

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Pharmacogenomics · 2022
    Article
  6. Global perspectives onFrontiers in pharmacology · 2022
    Review
  7. Review
  8. Genetic Variation ofFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rajeev K MehlotraCenter for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Andrea GaedigkDivision of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kanas City, MO, United States.
Rosalind E HowesBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Tovonahary A RakotomangaThe National Malaria Control Program, Ministry of Health, Antananarivo, Madagascar.
Arsene C RatsimbasoaThe National Malaria Control Program, Ministry of Health, Antananarivo, Madagascar.
Peter A ZimmermanCenter for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, United States.

Funding

Primaquine metabolism and treatment of P. vivax in MadagascarR01AI148469 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI WILLIAMS, SCOTT MATTHEW, ZIMMERMAN, PETER A. · 2020 to 2023
$2.6M
NIAID NIH HHS R01 AI148469
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CYP2D6hypnozoiteMadagascarmalaria treatmentPlasmodium vivaxprimaquine

Identifiers

PMID33959023
PMCPMC8093859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.